CELL & GENE THERAPY INSIGHTS

Spotlight

New horizons in cellular immunotherapy: next-gen platforms and modalities

Oct 2020
Guest Editor:
David Morrow, Scientific Programme Manager, Translational Medicine & Drug Development at EATRIS
David Morrow
Scientific Programme Manager, Translational Medicine & Drug Development at EATRIS

Expert Insight

Temferon™, an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy

Stefania Mazzoleni,
Bernhard Gentner,
Valentina Brambilla,
Tiziana Magnani,
Fabio Ciceri,
Gaetano Finocchiaro,
Luigi Naldini,
Carlo Russo
13 November 2020
Expert Insight

Engineering precision cell therapy for immune-mediated disease

Michael Milone,
Gwendolyn Binder
27 October 2020
Expert Insight

Immunological tolerance: scanning a barren landscape for signs of sustained growth

Harry Petropoulos,
Timothy J Davies,
Paul J Fairchild
28 September 2020
Expert Insight

Innovator Insight

Evolving the role of gene editing in cell therapy

Jonathan Frampton,
Torsten Meissner,
Tristan Thwaites
29 October 2020
Innovator Insight

Promising non-viral vector for efficient and versatile delivery of mRNA for antigen-specific immunotherapy

Rebuma Firdessa-Fite,
Jorge Postigo-Fernandez,
Valérie Toussaint-Moreau,
Fabrice Stock,
Dr Alengo Nyamay’antu,
Patrick Erbacher ,
Rémi Creusot
29 October 2020
Innovator Insight

Commentary

Developing harmonized immune platforms: a must-have for realizing personalized therapies in solid tumors

David Morrow,
Jan Langermans,
Anton Ussi,
Antonio Andreu,
Lucia Gabriele
20 October 2020
Commentary

Interview

Driving lupus out with CARs

Marko Radic
22 October 2020
Interview

Regulatory Insight

FDA perspective on the preclinical development of cell-based immunotherapies

Alyssa Kosmides Galaro,
Christopher Saeui
23 October 2020
Regulatory Insight

Report

Report

Other articles

Editorial

Expert Insight

Process development and scale-up of pluripotent stem cell manufacturing

Shuohao Huang,
Azher Razvi,
Zoe Anderson-Jenkins,
Danylo Sirskyj,
Ming Gong,
Anne-Marie Lavoie,
Gary Pigeau
22 October 2020
Expert Insight

Webinars

Evolving the role of gene editing in cell therapy

Evolving the role of gene editing in cell therapy

Jonathan Frampton
Jonathan Frampton, Horizon Discovery at Horizon Discovery
Tristan Thwaites
Tristan Thwaites, Lead Technical Scientist at Cell and Gene Therapy Catapult
Torsten Meissner
Torsten Meissner, Postdoctoral Fellow, Department of Stem Cell & Regenerative Biology at Harvard Medical School
6 October 2020
Webinar
Scalable AAV manufacturing – Addressing challenges across the workflow

Scalable AAV manufacturing – Addressing challenges across the workflow

Kenneth Thompson
Kenneth Thompson, Manager, R&D, Cell Biology at Thermo Fisher Scientific
Dr Chao Yan Liu
Dr Chao Yan Liu, Senior Manager, R&D, Cell Biology Thermo Fisher Scientific
John Li
John Li, Staff Scientist at Thermo Fisher Scientific
Michael Brewer
Michael Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
29 October 2020
Webinar